Cargando…

Claulansine F–Donepezil Hybrids as Anti-Alzheimer’s Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities

The multifactorial nature of Alzheimer’s disease (AD) calls for the development of multitarget agents addressing key pathogenic processes. A total of 26 Claulansine F–donepezil hybrids were designed and synthesized as multitarget drugs. Among these compounds, six compounds exhibited excellent acetyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Yingda, Liu, Ke, Wang, Weiping, Li, Chuangjun, Ma, Jie, Yang, Jingzhi, Chen, Xinyi, Wang, Xiaoliang, Zhang, Dongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957565/ https://www.ncbi.nlm.nih.gov/pubmed/33671020 http://dx.doi.org/10.3390/molecules26051303

Ejemplares similares

Neuroprotective effects of donepezil against cholinergic depletion
por: Cutuli, Debora, et al.
Publicado: (2013)

Novel Hydroxytyrosol-Donepezil Hybrids as Potential Antioxidant and Neuroprotective Agents
por: Costanzo, Paola, et al.
Publicado: (2021)

Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
por: Sadeghi, Mahdieh, et al.
Publicado: (2022)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67
por: Cui, Minhu, et al.
Publicado: (2020)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
por: Sabbagh, Marwan, et al.
Publicado: (2011)

Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease
por: Carotenuto, Anna, et al.
Publicado: (2022)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates
por: Piemontese, Luca, et al.
Publicado: (2018)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Novel Donepezil–Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer’s Disease
por: Queda, Fausto, et al.
Publicado: (2021)

Neuroprotective Effects of Sulforaphane on Cholinergic Neurons in Mice with Alzheimer’s Disease-Like Lesions
por: Zhang, Rui, et al.
Publicado: (2014)

Phytochemical Characteristics, Free Radical Scavenging Activities, and Neuroprotection of Five Medicinal Plant Extracts
por: Chang, Chia Lin, et al.
Publicado: (2012)

Radical Scavenging Activity and Pharmacokinetic Properties of Coumarin–Hydroxybenzohydrazide Hybrids
por: Antonijević, Marko R., et al.
Publicado: (2022)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Two new phenylpropanoid glycosides from the aerial parts of Lespedeza cuneata
por: Zhang, Chuangfeng, et al.
Publicado: (2016)

Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats
por: Pattanashetti, Laxmi Adiveppa, et al.
Publicado: (2017)

A New Ursane-Type Nor-Triterpenoid from the Leaves of Eucommia ulmoides Oliv.
por: Li, Chuangjun, et al.
Publicado: (2012)

Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease
por: Zhou, Yi, et al.
Publicado: (2023)

Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
por: Tao, Xiaojun, et al.
Publicado: (2021)

Neuroprotective effects of donepezil against Aβ(25-35)-induced neurotoxicity
por: Gao, Bu-Lang, et al.
Publicado: (2022)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Hardy, Chris J. D., et al.
Publicado: (2017)

Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
por: Yiannopoulou, Konstantina G., et al.
Publicado: (2019)

Blood Glutamate Scavenging: Insight into Neuroprotection
por: Leibowitz, Akiva, et al.
Publicado: (2012)

Profiling donepezil template into multipotent hybrids with antioxidant properties
por: Mezeiova, Eva, et al.
Publicado: (2018)

Fingerprints, Pharmaceutical and Radical Scavenging Activity Evaluation of an Alzheimer-Targeted Herbal Preparation
por: Dabaghian, Farid, et al.
Publicado: (2016)

Studies on Interaction of Buffalo Brain Cystatin with Donepezil: An Alzheimer's Drug
por: Amin, Fakhra, et al.
Publicado: (2013)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
por: Hwang, Yun Tae, et al.
Publicado: (2018)

Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Campbell, Tom A., et al.
Publicado: (2018)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
por: Chase, Thomas N., et al.
Publicado: (2017)

On the interaction of a donepezil-huprine hybrid with synthetic membrane models
por: Zambrano, Pablo
Publicado: (2022)

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
por: Park, Kee Hyung, et al.
Publicado: (2021)

Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease
por: Sang, Zhipei, et al.
Publicado: (2021)

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020
por: Kareem, Rzgar Tawfeeq, et al.
Publicado: (2021)

Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
por: Carocci, Alessia, et al.
Publicado: (2022)

Scavenging Effects of Dexrazoxane on Free Radicals
por: Junjing, Zhang, et al.
Publicado: (2010)

Evaluation of radical scavenging properties of shikonin
por: Yoshida, Lucia S., et al.
Publicado: (2014)

Is natural fraxin an overlooked radical scavenger?
por: Nam, Pham Cam, et al.
Publicado: (2021)

Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential
por: Liu, Qiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1s880jat7fh20csqe3mtmeqsgk